B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Erythropoietin activates RAS

REACTOME PATHWAY
Reactome: R-HSA-90272843 genes22 compounds

The Erythropoietin activates RAS pathway (Reactome ID: R-HSA-9027284) involves 3 genes and is affected by 22 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

GRB2JAK2LYN

Compounds Affecting Erythropoietin activates RAS

#CompoundTargets HitStudies
1Dasatinib299
2Azauridine300
3Cladribine297
4Methylene Blue200
52-Methoxyestradiol300
6Astemizole Antihistamine drug now withdrawn from280
7Azathioprine300
8Calcitriol300
9Camptothecin300
10Cytarabine297
11dihydrorotenone13
12Podophyllotoxin14
13streptonigrin299
14Trifluridine295
15Tripterygium300
16Sorafenib300
17tyrphostin ag 14784
18alsterpaullone12
19Crizotinib298
20kenpaullone8
21sp600125117
22Dactinomycin297

About the Erythropoietin activates RAS Pathway

The Erythropoietin activates RAS pathway is catalogued in Reactome (ID: R-HSA-9027284) and involves 3 genes. In the BiohacksAI corpus, 22 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include GRB2, JAK2, LYN.